Learn More About Our Dermatology Expertise
For your convenience, our brochures and case studies can be accessed here.
With more than two decades of dermatology experience Novella Clinical has provided support to 230+ programs and treated over 46,000 patients, in indications such as psoriasis, acne, atopic dermatitis and more.
This ebook is an RFP planning guide for small to mid-sized dermatology sponsors Understanding the primary cost drivers for dermatology clinical studies can be daunting. Novella Clinical developed this guide to help smaller dermatology sponsors better understand the nuances of … Read More
The evolution of biologics within the dermatology landscape Biologics present new treatment options for dermatology patients who haven’t seen positive results from traditional treatment methods, such as topicals, phototherapy or traditional drugs. This paper explores the evolution of biologics within … Read More
You require a CRO partner with dedicated experts and global site relationships. Our dermatology division is led by a team of specialists with 20+ years of experience and global in-house expertise spanning dermatology products and aesthetics. Download our brochure to … Read More
The difference between successful clinical trial enrollment and missed deadlines is comprehensive patient recruitment management planning. With more than a decade of patient recruitment experience and strong site relationships, Novella Clinical’s Dermatology Division provides innovative and cost-effective solutions to enhance patient … Read More
Designing effective and efficient clinical trials often lies in effective regulatory strategies. Novella Clinical’s Dermatology Division is ready to put our experience to work for you. From our years of interacting with the Food and Drug Administration (FDA), European Medicines … Read More
The integrity of clinical data is paramount to the successful reporting of clinical trial results. Novella Clinical’s Dermatology Division employs leading technologies that provide access to clinical trial data as well as status information throughout the trial. Our data management … Read More
After a delayed last patient in (LPI) date, Novella Clinical reviewed the tactics and helped devise and execute a campaign that helped sites complete enrollment for a Phase I and IIa acne vulgaris study in Canada.
Failure of sites to fulfill enrollment expectations on time often leads to major delays in clinical development programs. Novella Clinical was selected to conduct multiple large Phase III actinic keratosis studies, which involved from 60-960- patients in various sites in … Read More
When a global Phase II atopic dermatitis study faced numerous challenges, including language, cultural and time difference, ans well as seasonal fluctuations in disease prevalence, Novella Clinical was selected to provide recruitment/enrollment management, vendor management, a risk-based monitoring approach, system … Read More
Failure of sites to complete enrollment on time is a major cause of delays in clinical development programs. Relying on its expertise in dermatology, a leading pharmaceutical company engaged Novella Clinical’s patient recruitment team to assist with curtailing an enrollment … Read More
A 12-week study startup goal had been established by the sponsor of a Phase II multicenter efficacy and safety study on common warts, so sites were activated on a rolling basis to meet the first patient in (FPI) milestone. Working … Read More
A leading pharmaceutical company with a focus on men and women’s health selected Novella Clinical’s Dermatology Division to provide patient recruitment services for a Phase III external genital warts study. The sponsor selected Novella because of its reputation as a … Read More
Novella Clinical was asked to conduct a Phase III safety and efficacy study of a treatment for hyperhidrosis (excessive sweating) at sites in the US and Germany. The study required a large patient population in order to meet all the … Read More
A leading global pharmaceutical company selected Novella Clinical to support four large, international Phase III biologic studies in moderate to severe psoriasis. Novella’s Dermatology Division was selected because of its proven patient recruitment process with a record of enrollment that … Read More
A leading pharmaceutical company specializing in dermatology approached Novella Clinical to conduct a large Phase II onychomycosis study involving approximately 440 to 460 patients across 25 US and Canadian sites. Novella’s Dermatology Division was selected because of its reputation as … Read More
A leading global pharmaceutical company with a focus on dermatology selected Novella Clinical to conduct two large, Phase II psoriasis studies involving a combined 700 patients at 40 sites. Novella was challenged to achieve the sponsor’s goal of randomizing 300 … Read More
A leading global pharmaceutical company with a focus on dermatology selected Novella Clinical’s Dermatology Division to conduct a large Phase III psoriasis study involving over 1,100 patients at 60 sites. Novella was challenged to achieve the sponsor’s goal of randomizing … Read More